CIK 0001893219 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Abpro Holdings, Inc.
Sign in to watch- Tickers
- ABPO ABPWW
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 871013956
- Phone
- 248-890-7200
- Business address
- 6 ST JOHNS LANE, FLOOR 5, NEW YORK, NY, 10013
- Former names
- Atlantic Coastal Acquisition Corp. II
Securities
- ABPO Common stock OTC
- ABPWW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-13 | Markelewicz Robert J. Jr. Chief Medical Officer | Grant or award · Stock option (right to buy) | +40,800 | 40,800 | ||
| 2024-11-13 | Markelewicz Robert J. Jr. Chief Medical Officer | Grant or award · Stock option (right to buy) | +41,700 | 41,700 | ||
| 2024-11-13 | Markelewicz Robert J. Jr. Chief Medical Officer | Grant or award · Stock option (right to buy) | +74,600 | 74,600 | ||
| 2024-11-13 | Markelewicz Robert J. Jr. Chief Medical Officer | Grant or award · Stock option (right to buy) | +10,200 | 10,200 | ||
| 2023-11-07 | Ahmad Shahraab Chairman and CEO | Other disposition | −50,000 | 7,199,999 | ||
| 2023-11-06 | Kahlon Iqbaljit Director | Other disposition | −50,000 | 0 | ||
| 2023-11-06 | Ahmad Shahraab Chairman and CEO | Other acquisition | +50,000 | 7,249,999 | ||
| 2023-04-18 | Schiano Dominick Director | Option exercise | +50,000 | 50,000 | ||
| 2023-04-18 | Schiano Dominick Director | Option exercise · Series B Common Stock, par value $0.0001 per share | −50,000 | 0 | ||
| 2023-04-18 | Lord Joanna Director | Option exercise | +50,000 | 50,000 | ||
| 2023-04-18 | Lord Joanna Director | Option exercise · Series B Common Stock, par value $0.0001 per share | −50,000 | 0 | ||
| 2023-04-18 | Kahlon Iqbaljit Director | Option exercise | +50,000 | 50,000 | ||
| 2023-04-18 | Kahlon Iqbaljit Director | Option exercise · Series B Common Stock, par value $0.0001 per share | −50,000 | 0 | ||
| 2023-04-18 | Ahmad Shahraab Chairman and CEO | Option exercise | +7,199,999 | 7,199,999 | ||
| 2023-04-18 | Ahmad Shahraab Chairman and CEO | Option exercise · Series B Common Stock, par value $0.0001 per share | −7,199,999 | 1 | ||
| 2023-04-18 | Stanwood Darren Director | Option exercise | +50,000 | 50,000 | ||
| 2023-04-18 | Stanwood Darren Director | Option exercise · Series B Common Stock, par value $0.0001 per share | −50,000 | 0 | ||
| 2023-04-18 | Dove Bryan Director | Option exercise | +50,000 | 50,000 | ||
| 2023-04-18 | Dove Bryan Director | Option exercise · Series B Common Stock, par value $0.0001 per share | −50,000 | 0 | ||
| 2022-01-19 | Ahmad Shahraab Chairman and CEO | Other disposition · Series B Common Stock, par value $0.0001 per share | −50,000 | 7,203,750 |
Page 2 of 3 · 41 trades